Company Filing History:
Years Active: 2000-2003
Title: The Innovative Contributions of Andrew L Palma
Introduction
Andrew L Palma is a notable inventor based in San Ramon, CA. He has made significant contributions to the field of biochemistry, particularly in the development of novel peptides that have potential therapeutic applications. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Palma's latest patents focus on voltage-gated calcium channel antagonists. These patents describe a novel class of peptides that selectively block class E voltage-gated calcium channels. The class is exemplified by HG peptides, such as HG-1, which are isolated from the venom-producing cells of the tarantula Hysterocrates gigas. The patents also disclose methods for producing these blocking peptides, which have utility in inhibiting oxytocin release and can be used as anticonvulsants.
Career Highlights
Andrew L Palma is currently associated with Elan Pharmaceuticals, Inc., where he continues to innovate and contribute to the field. His work is characterized by a strong focus on the intersection of biochemistry and pharmacology, aiming to develop effective treatments for various medical conditions.
Collaborations
Throughout his career, Palma has collaborated with esteemed colleagues, including Robert W Newcomb and Balazs G Szoke. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Andrew L Palma's innovative work in the development of voltage-gated calcium channel antagonists showcases his commitment to advancing medical science. His contributions are not only significant in the realm of patents but also hold promise for future therapeutic applications.